SMG6

Source: Wikipedia, the free encyclopedia.
SMG6
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_001170957
NM_001256827
NM_001256828
NM_001282326
NM_017575

NM_001002764

RefSeq (protein)

NP_001243756
NP_001243757
NP_001269255
NP_060045

NP_001002764

Location (UCSC)Chr 17: 2.06 – 2.3 MbChr 11: 74.82 – 75.06 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Telomerase-binding protein EST1A is an

SNPs associated with increased risk of coronary artery disease.[12]

Structure

Gene

The SMG6 gene resides on chromosome 17 at the band 17p13.3 and contains 30

Protein

SMG6 is one of three human

complex with SMG5 and SMG7 when recruited by UPF1.[18]

Function

SMG6 is broadly expressed in all human tissues. It has dual functions in

NMD pathway. The catalytic activity of SMG6 resides in its PIN domain, which is required for the degradation of premature translation termination codons (PTC)-containing mRNAs in human cells.[20] SMG6 cleaves mRNA near the premature translocation-termination codons and requires UPF1 and SMG1 to reduce reporter mRNA levels.[21]

Clinical significance

In humans, selected genomic regions based on 150 SNPs were identified in a genome-wide association study (GWAS) on coronary artery disease. Accordingly, the association between recent smoking and the CpG sites within and near these coronary artery disease-related genes were investigated in 724 Caucasian subjects from the Rotterdam Study. The identified methylation sites were found in SMG6 together with other genes, and several of these sites exhibited lower methylation in subjects currently smoking compared to never smoking.[22]

Clinical marker

A multi-locus genetic risk score study based on a combination of 27 loci, including the SMG6 gene, identified individuals at increased risk for both incident and recurrent coronary artery disease events, as well as an enhanced clinical benefit from statin therapy. The study was based on a community cohort study (the Malmo Diet and Cancer study) and four additional randomized controlled trials of primary prevention cohorts (JUPITER and ASCOT) and secondary prevention cohorts (CARE and PROVE IT-TIMI 22).[12]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000070366Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038290Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^
    S2CID 14423276
    .
  6. ^ .
  7. ^ "Entrez Gene: SMG6 Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans)".
  8. ^ "BioGPS - your Gene Portal System". biogps.org. Retrieved 2016-10-12.
  9. PMID 16820686
    .
  10. .
  11. .
  12. ^ .
  13. ^ "SMG6 SMG6, nonsense mediated mRNA decay factor [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2016-10-12.
  14. ^ "SMG6 - Telomerase-binding protein EST1A - Homo sapiens (Human) - SMG6 gene & protein". www.uniprot.org. Retrieved 2016-10-12.
  15. PMID 17053788
    .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. .
  22. .

Further reading

This page is based on the copyrighted Wikipedia article: SMG6. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy